Related Experiment Video
Updated: Jul 16, 2026

04:14
In vivo Characterization of Endocrine Disrupting Chemical Effects via Thyroid Hormone Action Indicator Mouse
Published on: October 6, 2023
Current and potential rodent screens and tests for thyroid toxicants.
R Thomas Zoeller1, Rochelle W Tyl, Shirlee W Tan
1Biology Department, Morrill Science Center, University of Massachusetts-Amherst, Amherst, Massachusetts 01003, USA. tzoeller@bio.umass.edu
Critical Reviews in Toxicology
|March 17, 2007
Summary
This review examines rodent tests for thyroid toxicants, focusing on disruption points and current Organization for Economic Cooperation and Development (OECD) assays. It discusses adding new endpoints to improve detection of thyroid system disruption in developmental and adult studies.
Area of Science:
- Environmental Toxicology
- Endocrinology
- Reproductive and Developmental Toxicology
Background:
- Thyroid toxicants can disrupt multiple physiological pathways, including hormone levels, iodide uptake, and hormone action.
- Existing Organization for Economic Cooperation and Development (OECD), Japanese, and U.S. Environmental Protection Agency (EPA) assays use endpoints like thyroid gland weight, histopathology, and hormone levels.
- Understanding thyroid toxicant effects is crucial for human health risk assessment.
Purpose of the Study:
- To review current rodent screens and tests for detecting thyroid toxicants.
- To identify key disruption points in the thyroid system.
- To discuss the integration of novel endpoints into existing assays for enhanced detection of thyroid disruption.
Main Methods:
- Review of existing in vivo rodent assays and their endpoints (e.g., OECD, EPA protocols).
- Identification of potential disruption points for thyroid toxicants.
- Discussion of novel endpoints under development, including molecular and neurodevelopmental assessments.
Main Results:
- Current assays primarily measure thyroid gland weight, histopathology, serum thyroid hormones, and thyroid-stimulating hormone (TSH).
- Numerous potential disruption points exist, including effects on thyroperoxidase, iodide uptake, deiodinases, and hormone action.
- New endpoints, such as gene expression and neurodevelopmental assessments, show promise but require further validation.
Conclusions:
- In vivo rodent assays are currently the most appropriate for assessing thyroid toxicants.
- Adding strategic endpoints can improve the detection of thyroid system disruption.
- Further research and development are needed for novel endpoints to be incorporated into regulatory guidelines.

